{"id":8709,"date":"2021-11-22T12:53:47","date_gmt":"2021-11-22T03:53:47","guid":{"rendered":"http:\/\/health.re.kr\/?p=8709"},"modified":"2022-01-06T18:03:17","modified_gmt":"2022-01-06T09:03:17","slug":"a-situational-analysis-of-equitable-access-to-covid-19-technologies-in-south-korea","status":"publish","type":"post","link":"http:\/\/health.re.kr\/?p=8709","title":{"rendered":"A situational analysis of Equitable Access to COVID-19 Technologies in South Korea"},"content":{"rendered":"

EACT \ud55c\uad6d \ud504\ub85c\uc81d\ud2b8\uac00 1\ub144\uac04\uc758 \ud65c\ub3d9\uc744 \ub9c8\ubb34\ub9ac\ud558\uba70 \uc791\uc131\ud55c \ubcf4\uace0\uc11c <\ud55c\uad6d\uc758 \ucf54\ub85c\ub09819 \uae30\uc220 \uc811\uadfc\uc131 \uc0c1\ud669 \ubd84\uc11d>\uc744 \uacf5\uac1c\ud569\ub2c8\ub2e4.<\/span><\/p>\n

\uc2dc\ubbfc\uac74\uac15\uc5f0\uad6c\uc18c\ub294<\/span> \ud55c\uad6d\ubbfc\uc911\uac74\uac15\uc6b4\ub3d9(PHM Korea)<\/span><\/a> \uc0ac\ubb34\uad6d\uc73c\ub85c\uc11c, \ubbfc\uc911\uac74\uac15\uc6b4\ub3d9(PHM)\uc758 \uae00\ub85c\ubc8c \ud504\ub85c\uc81d\ud2b8<\/span> ‘\ucf54\ub85c\ub09819 \ub9e5\ub77d\uc5d0\uc11c \ud544\uc218\ubcf4\uac74\uae30\uc220\uc5d0 \ub300\ud55c \uacf5\ud3c9\ud55c \uc811\uadfc \ucd09\uc9c4\ud558\uae30(EACT)’ \ud504\ub85c\uc81d\ud2b8<\/span><\/a>\uc5d0 \ucc38\uc5ec\ud588\uc2b5\ub2c8\ub2e4.<\/span><\/p>\n

EACT \ud504\ub85c\uc81d\ud2b8\ub294 \uae30\uc220 \uc811\uadfc\uacfc \uad00\ub828\ub41c \uc815\ucc45\ub4e4\uc774 \uc2dc\uc7a5 \uc6d0\ub9ac\uc640 \uae30\uc5c5 \uc774\uc724 \ub300\uc2e0 \uacf5\uc911\ubcf4\uac74 \uc6b0\uc120\uc21c\uc704\uc5d0 \uae30\ucd08\ud560 \uc218 \uc788\ub3c4\ub85d, \uc815\ubd80 \ubc0f \uad6d\uc81c\uae30\uad6c\ub4e4\uacfc \uacf5\uc801 \ub2f4\ub860\uc744 \uacac\uc778\ud55c\ub2e4\ub294 \ubaa9\ud45c\ub97c \uac00\uc9c0\uace0 2020\ub144 7\uc6d4\ubd80\ud130 2021\ub144 6\uc6d4\uae4c\uc9c0 \ud65c\ub3d9\ud588\uc2b5\ub2c8\ub2e4.<\/span> EACT \ud55c\uad6d \ud504\ub85c\uc81d\ud2b8<\/span><\/a>\uc5d0\ub294 \uc2dc\ubbfc\uac74\uac15\uc5f0\uad6c\uc18c, PHM Korea \ud3a0\ub85c\uc6b0, \uac74\uac15\uc0ac\ud68c\ub97c\uc704\ud55c\uc57d\uc0ac\ud68c\uac00 \ud568\uaed8 \ud588\uc2b5\ub2c8\ub2e4.<\/span><\/p>\n

EACT \ud55c\uad6d \ud504\ub85c\uc81d\ud2b8\uc758 \ud65c\ub3d9\uc740 \ud06c\uac8c (1) ‘\ucf54\ub85c\ub09819 \ud32c\ub370\ubbf9 \ub9e5\ub77d\uc5d0\uc11c \uc758\ub8cc\uae30\uc220\uc5d0 \ub300\ud55c \uc811\uadfc’\uacfc \uad00\ub828\ud55c \uadfc\uac70 \uc790\ub8cc \uc0dd\uc0b0, (2) \uadf8\ub97c \ud1b5\ud55c ‘\uacf5\ud3c9\ud55c \uc811\uadfc\uc744 \ucd09\uc9c4\ud558\uae30’ \uc704\ud55c \uc6b4\ub3d9, \ub450 \uac00\uc9c0\ub85c \uc694\uc57d\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/span><\/p>\n

EACT \ud55c\uad6d \ud504\ub85c\uc81d\ud2b8\ub294 <\ud55c\uad6d\uc758 \ucf54\ub85c\ub09819 \uae30\uc220 \uc811\uadfc\uc131 \uc0c1\ud669 \ubd84\uc11d> \ubcf4\uace0\uc11c\ub97c \ud1b5\ud574 (1) \ud55c\uad6d\uc5d0\uc11c \ucf54\ub85c\ub09819 \uc0c1\ud669\uc5d0 \ub530\ub77c \uae30\uc220 \uc811\uadfc\uc131\uacfc \uad00\ub828 \ubb38\uc81c\uac00 \uc5b4\ub5bb\uac8c \ubcc0\ud654\ud588\ub294\uc9c0, (2) \ud55c\uad6d \uc2dc\ubbfc\uc0ac\ud68c\uac00 ‘\ucf54\ub85c\ub09819 \ud32c\ub370\ubbf9 \ub9e5\ub77d\uc5d0\uc11c \uc758\ub8cc\uae30\uc220\uc5d0 \ub300\ud55c \uacf5\ud3c9\ud55c \uc811\uadfc\uc744 \ucd09\uc9c4\ud558\uae30(EACT)’ \uc704\ud574 \ubd84\ud22c\ud574 \uc628 \uacfc\uc815\uc5d0\uc11c \uacbd\ud5d8\ud55c \uc8fc\uc694 \uad50\ud6c8\uacfc \ub3c4\uc804\uacfc\uc81c\ub294 \ubb34\uc5c7\uc778\uc9c0, \ubd84\uc11d\ud558\uace0 \uc774\ub97c \uacf5\uc720\ud558\uace0\uc790 \ud558\uc600\uc2b5\ub2c8\ub2e4.<\/span><\/p>\n

\ubcf4\uace0\uc11c\ub97c \ud1b5\ud574, \ucf54\ub85c\ub09819 \uae30\uc220\uc5d0 \ub300\ud55c \uacf5\ud3c9\ud55c \uc811\uadfc\uacfc \uc9c0\uc801\uc7ac\uc0b0\uad8c \uc7a5\ubcbd \uadf9\ubcf5\uc744 \uc704\ud55c \ud55c\uad6d \uc2dc\ubbfc\uc0ac\ud68c\uc758 \uc6b4\ub3d9\uacfc \uae00\ub85c\ubc8c \uc5f0\ub300 \uc6b4\ub3d9\uc758 \ud750\ub984\uc744 \ud655\uc778\ud558\uace0, \ub354 \ub9ce\uc740 \uc774\ub4e4\uc774 \uad00\ub828 \uc6b4\ub3d9\uacfc \uc5f0\uad6c \ud65c\ub3d9\uc5d0 \ud568\uaed8 \ud560 \uc218 \uc788\uae30\ub97c \ubc14\ub78d\ub2c8\ub2e4.<\/span><\/p>\n

\u00a0<\/span><\/p>\n

CONTENTS<\/span><\/p>\n

    \n
  1. Overview 1<\/span><\/li>\n
  2. Introduction 2<\/span><\/li>\n
  3. Methods 3<\/span><\/li>\n
  4. Situational campaigns for EACT 4<\/span>\n
      \n
    1. Stage 1: Continuing IP & A2M actions in South Korea (July 2020 – October 2020) 4<\/span><\/li>\n
    2. Stage 2: Blooming of the Korean advocacy for India-South Africa TRIPS Waiver (October 2020 – February 2021) 7<\/span><\/li>\n
    3. Stage 3: Standing with the TRIPS Waiver Proposal (February 2021 – June 2021) 10<\/span>\n
        \n
      1. Wave 1 11<\/span><\/li>\n
      2. Wave 2 12<\/span><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<\/li>\n
      3. Situational case studies on Korean pharmaceutical systems and A2M amid COVID-19 17<\/span>\n
          \n
        1. Public R&D in South Korea (January, 2021) 17<\/span><\/li>\n
        2. Korean firm Celltrion\u2019s Regkirona (From November 2020 to February 2021) 18<\/span><\/li>\n
        3. The TRIPS Waiver Proposal and Korean societies (March 2021) 20<\/span><\/li>\n
        4. The COVID-19 diagnostic kits industry in South Korea (June 2021) 21<\/span><\/li>\n
        5. Public manufacturing in South Korea (July 2021) 22<\/span><\/li>\n
        6. Equitable vaccine distributions for the marginalized population in Korea (From January 2021 to April 2021) 24<\/span><\/li>\n<\/ol>\n<\/li>\n
        7. Concluding notes 25<\/span><\/li>\n
        8. Annexes 26<\/span><\/li>\n<\/ol>\n

          \u00a0<\/span><\/p>\n

          People\u2019s Health Movement Korea (PHM Korea hereafter) and its solidarity network conducted a project called Equitable Access for COVID-19 Technologies (EACT) organized by the People\u2019s Health Movement (PHM) and supported by the Open Society Foundations from July 2020 to June 2021. The purpose of this report is that (1) identify key lessons and challenges doing health activism amid COVID-19 for other activists and solidarity groups and (2) measure technology issues and access to medicines in South Korea along with the indicator of COVID-19. Both goals supplement PHM\u2019s long term visions for Health for All.<\/span><\/p>\n

          Drawing from the situational analysis, the main findings of this report consist of two parts: (1) EACT Korea as health activism and (2) EACT Korea as evidence and data production.<\/span><\/p>\n

          Regarding EACT Korea as activism, our actions and campaigns are summarised in the following:<\/span><\/p>\n